Area of research
Oncology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, CAR-T cell therapy research, and COVID-19 and healthcare impacts.
Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With Cancer.
Inhibition of the PD-1 immune checkpoint and the development of heart failure in the presence of prior cardiac ischemia.
Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors.
Data from Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Supplementary Table 4 from Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Supplementary Table 3 from Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Supplementary Table 2 from Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Table 2 from Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Supplementary Table 1 from Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Supplementary Figure 1 from Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Table 3 from Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Table 1 from Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Figure 1 from Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Figure 2 from Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy
Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.
Predictors of Long-Term Survival in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
Beyond the Point: Learning From Outcomes After Inpatient Immune Checkpoint Inhibitor Therapy.
It Takes a Village! Navigating the Challenges and Opportunities in Immune-Related Adverse Event Management.
Immune responses in checkpoint myocarditis across heart, blood and tumour
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis
Cardiovascular Considerations Before Cancer Therapy
Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study
Identification of Immune Checkpoint Inhibitor–Induced Diabetes
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records.
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor–associated acute kidney injury
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis.
A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report.